Shares of Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report) traded up 16% on Friday . The company traded as high as $31.15 and last traded at $31.15. 1,863 shares were traded during trading, an increase of 250% from the average session volume of 533 shares. The stock had previously closed at $26.85.
Pharma Mar Stock Up 16.0 %
The company has a debt-to-equity ratio of 0.13, a current ratio of 3.01 and a quick ratio of 2.61. The business has a fifty day simple moving average of $30.04 and a 200-day simple moving average of $36.84.
About Pharma Mar
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, France, rest of EU, the United States, and internationally. The company operates through Oncology and RNA interference segments.
See Also
- Five stocks we like better than Pharma Mar
- ESG Stocks, What Investors Should Know
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Short Selling: How to Short a Stock
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- 3 Grocery Stocks That Are Proving They Are Still Essential
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
